{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:34:09Z","timestamp":1790840049412,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12010-021-03657-y","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T01:02:30Z","timestamp":1632272550000},"page":"827-847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pyridine Borane as Alternative Reducing Agent to Sodium Cyanoborohydride for the PEGylation of L-asparaginase"],"prefix":"10.1007","volume":"194","author":[{"given":"Santosh","family":"Gurram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnupriya","family":"Badve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Nandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridevi","family":"Gundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"3657_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/aps.2019.20201","volume":"3","author":"NA Abdelrazeka","year":"2019","unstructured":"Abdelrazeka, N. A., Elkhatibb, W. F., Raafata, M. M., & Aboulwafac, M. M. (2019). Diverse origins of microbial L-asparaginases and their current miscellaneous applications. Archives of Pharmaceutical Sciences Ain Shams University, 3, 1.","journal-title":"Archives of Pharmaceutical Sciences Ain Shams University"},{"key":"3657_CR2","doi-asserted-by":"crossref","unstructured":"Farag, A. M., Hassan, S. W., Beltagy, E. A., & El-Shenawy, M. A. (2015). Optimization of production of anti-tumor l-asparaginase by free and immobilized marine Aspergillusterreus. Egyptian Journal of Aquatic Research, 41.","DOI":"10.1016\/j.ejar.2015.10.002"},{"key":"3657_CR3","doi-asserted-by":"crossref","unstructured":"Shrivastava, A., Khan, A. A., Khurshid, M., Kalam, M. A., Jain, S. K., &Singhal, P. K. (2016). Recent developments in L-asparaginase discovery and its potential as anticancer agent. Critical Reviews in Oncology\/Hematology, 100.","DOI":"10.1016\/j.critrevonc.2015.01.002"},{"key":"3657_CR4","doi-asserted-by":"crossref","unstructured":"Giovanna, P. M., Jo\u00e3o H. P., Karin M. T., Christiano M. V. (2019). Novel site-specific PEGylated L-asparaginase. PLOS ONE, 14, (2).","DOI":"10.1371\/journal.pone.0224592"},{"key":"3657_CR5","doi-asserted-by":"crossref","unstructured":"Heo, Y., Syed, Y. Y., & Keam, S. J. (2019). Pegaspargase: A review in acute lymphoblastic leukaemia, Drugs, 79.","DOI":"10.1007\/s40265-019-01120-1"},{"key":"3657_CR6","unstructured":"Josell, R., Saxena, M., Louis, J. D., Freisa, M. J., Shiru, L., Zhongfang, C., Virginia, A. R., Kai, G. (2018). Site-specific PEGylation crosslinking of L-asparaginase subunits to improve its therapeutic efficiency. PLOS ONE, 13(7)."},{"key":"3657_CR7","doi-asserted-by":"crossref","unstructured":"Lane, C. F. (1975). Sodium cyanoborohydride - A highly selective reducing agent for organic functional groups. Synthesis, 3.","DOI":"10.1055\/s-1975-23685"},{"key":"3657_CR8","doi-asserted-by":"crossref","unstructured":"Ambrogelly, A., Cutler, C., & Paporello, B. (2013). Screening of reducing agents for the PEGylation of recombinant human IL-10. The Protein Journal, 32.","DOI":"10.1007\/s10930-013-9491-4"},{"key":"3657_CR9","first-page":"2","volume":"265","author":"HY Yeang","year":"1998","unstructured":"Yeang, H. Y., Yusof, F., & Abdullah, L. (1998). Protein purification for the Lowry assay: Acid precipitation of proteins in the presence of sodium dodecyl sulfate and other biological detergents. Analytical Biochemistry, 265, 2.","journal-title":"Analytical Biochemistry"},{"key":"3657_CR10","doi-asserted-by":"crossref","unstructured":"Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227.","DOI":"10.1038\/227680a0"},{"key":"3657_CR11","first-page":"30","volume":"3","author":"N Dyballa","year":"2009","unstructured":"Dyballa, N., & Metzger, S. (2009). Fast and sensitive colloidal coomassie G-250 staining for proteins in polyacrylamide gels. Journal of Visualized Experiments, 3, 30.","journal-title":"Journal of Visualized Experiments"},{"key":"3657_CR12","doi-asserted-by":"crossref","unstructured":"Blancher, C., & Jones, A. (2001). SDS-PAGE and Western blotting techniques. Methods in Molecular Medicine, 57.","DOI":"10.1385\/1-59259-136-1:145"},{"key":"3657_CR13","doi-asserted-by":"crossref","unstructured":"Perobelli, R., Xavier, B., Silveira, A., Remuzzi, G., Motta, L.,& Dalmora, S. (2018). Quantitation of the monoclonal antibody denosumab by bioassay and validated LC methods. International Journal of Biological Macromolecules, 119.","DOI":"10.1016\/j.ijbiomac.2018.07.120"},{"key":"3657_CR14","first-page":"5","volume":"48","author":"N Li","year":"2008","unstructured":"Li, N., Ziegemeier, D., Bass, L., & Wang, W. (2008). Quantitation of free polyethylene glycol in PEGylated protein conjugate by size exclusion HPLC with refractive index (RI) detection. Journal of Pharmaceutical and Biomedical Analysis, 48, 5.","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"3657_CR15","unstructured":"Daniel, S., Hadar, A., Ayala, T., Mario, L. (2019). Characterization of proteins by size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS). Journal of visual experiments, (148)."},{"key":"3657_CR16","doi-asserted-by":"crossref","unstructured":"Mostafa, T. & Brennan, S. (2020). Development and optimization of a reversed-phase HPLC method to separate pulse proteins. Food Analytical Methods. 13.","DOI":"10.1007\/s12161-020-01771-x"},{"key":"3657_CR17","doi-asserted-by":"crossref","unstructured":"Khalifa, I., Nie, R., Ge, Z., Li, K., & Li, C. (2018). Understanding the shielding effects of whey protein on mulberry anthocyanins: Insights from multispectral and molecular modeling investigations. International Journal of Biological Macromolecules, 119.","DOI":"10.1016\/j.ijbiomac.2018.07.117"},{"key":"3657_CR18","doi-asserted-by":"crossref","unstructured":"Upadhyay, A., Singh, A., Mukherjee, K., &Panda, A. (2014). Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein. Frontiers in Microbiology, 5, 486.","DOI":"10.3389\/fmicb.2014.00486"},{"key":"3657_CR19","doi-asserted-by":"crossref","unstructured":"Wriston, J. C. (1985). Asparaginase. Methods in Enzymology, 113.","DOI":"10.1016\/S0076-6879(85)11007-4"},{"key":"3657_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0960-894X(01)81162-8","volume":"1","author":"JA Barltrop","year":"1991","unstructured":"Barltrop, J. A., Terence, C., Ann, H., & Joseph, G. (1991). 5-(3-carboxymethoxyphenyl)-2-(4, 5-dimethylthiazoly)-3-(4- sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5- dimethyl thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple milliQ water soluble formazans as cell-viability indicators. Bioorganic & Medicinal Chemistry Letters, 1, 11.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"3657_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 1\u20132.","journal-title":"Journal of Immunological Methods"},{"key":"3657_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-1759(94)00277-4","volume":"179","author":"CJ Goodwin","year":"1995","unstructured":"Goodwin, C. J., Holt, S. J., Downes, S., & Marshall, N. J. (1995). Micro culture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS. Journal of Immunological Methods, 179, 1.","journal-title":"Journal of Immunological Methods"},{"key":"3657_CR23","unstructured":"CellTiter 96\u00ae Non-radioactive cell proliferation assay. Technical Bulletin, #TB112, Promega Corporation."},{"key":"3657_CR24","first-page":"3","volume":"139","author":"YM Kwon","year":"2009","unstructured":"Kwon, Y. M., Chung, H. S., Moon, C., Yockman, J., Yoon, J. P., Gitlin, S. D., David, A. E., & Yang, V. C. (2009). L-asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). Journal of Controlled Release, 139, 3.","journal-title":"Journal of Controlled Release"},{"key":"3657_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(02)00042-1","volume":"80","author":"FW Holtsberg","year":"2002","unstructured":"Holtsberg, F. W., Ensor, C. M., Steiner, M. R., Bomalaski, J. S., & Clark, M. A. (2002). Poly(ethylene glycol) (PEG) conjugated arginine deiminase: Effects of PEG formulations on its pharmacological properties. Journal of Controlled Release, 80, 1\u20133.","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"3657_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2867-9-9","volume":"9","author":"SM Tsui","year":"2009","unstructured":"Tsui, S. M., Lam, W. M., Lam, T. L., Chong, H. C., So, P. K., Kwok, S. Y., Arnold, S., Cheng, P. N. M., Wheatley, D. N., Lo, W. H., & Leung, Y. C. (2009). Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in-vivo activity in cancer therapy: Preparation, characterization and analysis of their pharmacodynamics in-vivo and in vitro and action upon hepatocellular carcinoma cell (HCC). Cancer Cell International, 9(1), 9.","journal-title":"Cancer Cell International"},{"key":"3657_CR27","doi-asserted-by":"crossref","unstructured":"Duncan, R.,& Spreafico, F. (1994). Polymer conjugates pharmacokinetic considerations for design and development. Clinical Pharmacokinetics, 27.","DOI":"10.2165\/00003088-199427040-00004"},{"key":"3657_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.critrevonc.2006.07.009","volume":"61","author":"UK Narta","year":"2007","unstructured":"Narta, U. K., Kanwar, S. S., & Azmi, W. (2007). Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Critical Reviews in Oncology\/Hematology, 61, 3.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"3657_CR29","doi-asserted-by":"crossref","unstructured":"Braun, A. C., Gutmann, M., Mueller, T. D., L\u00fchmann, T., &Meinel, L. (2018). Bioresponsive release of insulin-like growth factor-I from its PEGylated conjugate. Journal of Controlled Release, 279.","DOI":"10.1016\/j.jconrel.2018.04.009"},{"key":"3657_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.06.077","volume":"454","author":"S Koussoroplis","year":"2013","unstructured":"Koussoroplis, S., Heywood, S., Uyttenhove, C., Barillya, C., Van Snick, J., & Vanbever, R. (2013). Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragments. International Journal of Pharmaceutics, 454, 1.","journal-title":"International Journal of Pharmaceutics"},{"key":"3657_CR31","doi-asserted-by":"crossref","unstructured":"VanLeeuwen, L., Hinchy, E. C., Murphy, M. P., Robb, E. L., & Cochem\u00e9, H. M. (2017). Click-PEGylation - A mobility shift approach to assess the redox state of cysteines in candidate proteins. Free radical biology & Medicine, 108.","DOI":"10.1016\/j.freeradbiomed.2017.03.037"},{"key":"3657_CR32","doi-asserted-by":"crossref","unstructured":"Abed, H. S., Al-Ghobashy, M. A., Fathalla, F. A., & Salem, M. Y. (2017). Evaluation of the combined effects of PEGylation and glycosylation on the stability of erythropoietin using a stability indicating SE-HPLC. Biologicals, 50.","DOI":"10.1016\/j.biologicals.2017.08.012"},{"key":"3657_CR33","unstructured":"Fee, C. J., Van Alstine, J. M. (2005). Separation of PEGylated proteins by size exclusion chromatography: Influence of PEGylation on molecular size. J-stage"},{"key":"3657_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms161025831","volume":"16","author":"JK Dozier","year":"2015","unstructured":"Dozier, J. K., & Distefano, M. D. (2015). Site-specific PEGylation of therapeutic proteins. International Journal of Molecular Sciences, 16, 10.","journal-title":"International Journal of Molecular Sciences"},{"key":"3657_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jps.24253","volume":"104","author":"R Liebner","year":"2015","unstructured":"Liebner, R., Meyer, M., Hey, T., Winter, G., & Besheer, A. (2015). Head to head comparison of the formulation and stability of concentrated solutions of HESylated versus PEGylated Anakinra. Journal of Pharmaceutical Sciences, 104, 2.","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"3657_CR36","first-page":"2","volume":"4","author":"CJ White","year":"2018","unstructured":"White, C. J., & Bode, J. W. (2018). PEGylation and dimerization of expressed proteins under near equimolar conditions with potassium 2-pyridyl acyltrifluoroborates. ACS Central Science, 4, 2.","journal-title":"ACS Central Science"},{"key":"3657_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15171\/apb.2016.043","volume":"6","author":"P Akbarzadehlaleh","year":"2016","unstructured":"Akbarzadehlaleh, P., Mirzaei, M., Mashahdi-Keshtiban, M., Shamsasenjan, K., & Heydari, H. (2016). PEGylated human serum albumin: Review of PEGylation, purification and characterization methods. Advanced Pharmaceutical Bulletin, 6, 3.","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"3657_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0014-5793(84)80741-3","volume":"175","author":"P Manavalan","year":"1984","unstructured":"Manavalan, P., & Johnson jr. W. C., & Johnston, P. D. . (1984). Prediction structure type for human leukocyte interferon subtype A from circular dichroism. FEBS Letters, 175, 2.","journal-title":"FEBS Letters"},{"key":"3657_CR39","doi-asserted-by":"crossref","unstructured":"Lawrence, P. B., & Price, J. L. (2016). How PEGylation influences protein conformational stability. Current Opinion in Chemical Biology, 34.","DOI":"10.1016\/j.cbpa.2016.08.006"},{"key":"3657_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/nano.2006.1.1.3","volume":"1","author":"VI Avramis","year":"2006","unstructured":"Avramis, V. I., & Tiwari, P. N. (2006). Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. International journal of nanomedicine, 1, 3.","journal-title":"International journal of nanomedicine"},{"key":"3657_CR41","unstructured":"Highlights of prescribing information of Oncaspar(2007). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/103411s5052lbl.pdf."},{"key":"3657_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-5173(96)04583-8","volume":"141","author":"J Acobsen","year":"1996","unstructured":"Acobsen, J., Pedersen, M., & Rassing, M. R. (1996). TR146 cells as a model for human buccal epithelium: II. Optimization and use of a cellular sensitivity MTS\/PMS assay. International Journal of Pharmaceutics, 141, 1\u20132.","journal-title":"International Journal of Pharmaceutics"},{"key":"3657_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.36468\/pharmaceutical-sciences.502","volume":"81","author":"T Rahimnejad","year":"2019","unstructured":"Rahimnejad, T., Beshkar, P., Bagheri, R., & Pourgheysari, B. (2019). Pterostilbene enhances anticancer effects of L-asparaginase in lymphoblastic leukemia cell line. Indian Journal of Pharmaceutical Sciences, 81, 2.","journal-title":"Indian Journal of Pharmaceutical Sciences"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-021-03657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-021-03657-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-021-03657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T12:45:16Z","timestamp":1644237916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-021-03657-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3657"],"URL":"https:\/\/doi.org\/10.1007\/s12010-021-03657-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"26 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This information is not relevant since our study does involve neither animals nor human.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable since our manuscript does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}